8-KThe WireRed Alert
Executive Change · Bylaw Amendment
Filed Jun 5, 2025 · 1y ago · Accession 0001558370-25-008430
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Aclaris Therapeutics, Inc.
- Ticker
- ACRS
- CIK
- 1557746
- Form type
- 8-K
- Filing date
- Jun 5, 2025
- Report date
- Jun 5, 2025
- Document
- acrs-20250605x8k.htm
- Size
- 585 KB